Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary...
GOSS is a biotechnology penny stock without earnings valued based on future earnings
potential based on a "pipeline" which is subject to a long timeline of FDA regulation.
On the 30 minute chart. price is shown as being in the overvalued area in the upper VWAP
band and well above the POC line of the long-range volume profile. The RSI indicator is
now...
This is not a financial advice!
Upcoming catalyst and block buys recently.
SL under 0.97
Key level: 1.4 must be broken and hold for bullish confirmation.
TP 1 around 3.0
TP 2 around 6.0
TP 3 around 9.0
Only 89.93M float
18.97% Short float
Most info on the chart.
Trade carefully!
There is a good buy opportunity when you look at daily or weekly graphs.it is oversold and rsi is at the bottom.
Minimum Target for the next 20-30 days around $3 $4
Biotechnology is the favorite sector of one of our analysts, most of his portfolio consists of biotechs, and he himself claims that it is the cryptocurrency of the common stock market.
Why? Let's explain :
High risk/reward and high volatility.
Imagine this: you invest in a company that has no revenue or any specific product, yet you believe in the idea it...
This stock jumped to the top of my proprietary algorithm about 2 weeks ago; set the alert and it fired a few days ago.
The chart shown is as simple as it gets; see expected price action on chart and be sure to review the comments box.
Set your alerts, stop loss, etc. as needed.
Feedback always welcome.
I have 2 versions of this chart to publish; this is the complex visual that includes all of the channel color-coded.
See comments on the chart for details.
Gossamer Bio
Healthcare
Biotechnology
USA
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States and is headquartered in San Diego, California.
- High volume in stock
- Crossed 200 EMA
-...
GOSS has a good potential for a short squeeze. Information as of now are below:
Shares Short 11.06 M
Shares Short (prior month) 8.37 M
Short % Of Float 22.58 %
Days To Cover 16.4
Mo Over Mo % Change 32.14 %
Over the last month, GOSS has managed to break out of the big RED falling channel, and in the last sessions, it looks like it may also be breaking out of the big BLACK symmetrical triangle. This morning it has traded as high as 9% above yesterday's close, and while the day is still long, these are exciting signs of life indeed. If it can gather some momentum, it...
